The University of Arizona College of Medicine and the Mulidisciplinary Association for Psychedelic Studies (MAPS) has received tentative approval from the U.S. Food and Drug Administration (FDA) to study the use of marijuana in the possible treatment of post-traumatic stress disorder among veterans. There are additional hurdles that must be overcome before research may commence. MAPS is the only U.S. organization pursuing research involving botanical marijuana that has received this type of support so far from the FDA.
Source: http://www.stripes.com/news/marijuana-treatment-sought-for-chronic-ptsd-sufferers-1.149688
Additional Information: Mulidisciplinary Association for Psychedelic Studies (MAPS)
No comments:
Post a Comment